Application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or/and treating viral diseases, and medicine or health care product for treating viral diseases

The present invention discloses a composition of phillyrin and phillygeninin in the preparation of drugs for alleviating or/and treating viral diseases. Experiments prove that the composition of phillyrin and phillygeninin has significant treatment effects on viral influenza and pneumonia, as well as on respiratory syncytial viruses, enteroviruses, herpes zoster simplex viruses, Coxsackie viruses, and the like. This composition is characterized by quick action and less toxic and side effects, and thus is an antiviral drug and health product with safety, high efficiency, stability and simple preparation process, and is suitable for industrial production and easy to promote. The present invention provides a drug, health product and raw material for preventing and treating various viral diseases.

SYSTEM TO REUSE FATS, OILS AND GREASE

A method of forming a yellow grease is provided. The method includes delivering a FOG lipid extraction agent into a processing tank. The method further includes preheating a waste grease to a temperature of between 35° C. and 95° C. The method further includes mixing the preheated waste grease with the FOG lipid extraction agent in the processing tank to form the yellow grease.

METHOD OF EXTRACTING LIPIDS FROM TRAP GREASE WITH WASTE COOKING OIL

Describe are methods of extracting the lipid fraction from trap grease using vegetable oil, such as vegetable oils sourced from waste cooking oil. The method includes mixing a volume of vegetable oil with a volume of trap grease. The mixture is comprised of an aqueous fraction, a solid fraction, and a lipid fraction. The mixture is heated to a temperature in a range from about 50 degrees C. to about 100 degrees C. for a period of time sufficient to extract at least 80 percent of the lipids from the trap grease. The lipid fraction is then separated from the solid fraction. The method may further include a process of producing biodiesel from the extracted lipid fraction.

Process for making biofuel from spent coffee grounds

A system and process for producing biofuel from spent coffee grounds (SCGs) comprises the steps of performing a first operation comprising the steps of obtaining spent SCGs from a source, washing the SCGs, mixing the washed SCGs with an inorganic acid and heating and stirring the washed SCGs to form a SCG slurry without separating coffee oil, drying the SCG slurry, mixing the dried slurry with a solvent and heating the dried slurry and solvent mixture to create a reaction to produce biofuel and residual grounds, and separating the biofuel from the solvent and the residual grounds. The process further includes the step of using an activation agent and heating the residual grounds and the activation agent to create activated residual grounds. Biochar is also produced without activation and heating de-oiled SCGs at lower temperatures without oxygen.

System to reuse fats, oils and grease

A method of forming a yellow grease is provided. The method includes delivering a FOG lipid extraction agent into a processing tank. The method further includes preheating a waste grease to a temperature of between 35° C. and 95° C. The method further includes mixing the preheated waste grease with the FOG lipid extraction agent in the processing tank to form the yellow grease.

METHOD OF EXTRACTING LIPIDS FROM TRAP GREASE WITH WASTE COOKING OIL

Describe are methods of extracting the lipid fraction from trap grease using vegetable oil, such as vegetable oils sourced from waste cooking oil. The method includes mixing a volume of vegetable oil with a volume of trap grease. The mixture is comprised of an aqueous fraction, a solid fraction, and a lipid fraction. The mixture is heated to a temperature in a range from about 50 degrees C. to about 100 degrees C. for a period of time sufficient to extract at least 80 percent of the lipids from the trap grease. The lipid fraction is then separated from the solid fraction. The method may further include a process of producing biodiesel from the extracted lipid fraction. 1. A method of extracting a lipid fraction from trap grease comprising:mixing a volume of vegetable oil with a volume of trap grease, wherein the mixture is comprised of an aqueous fraction, a solid fraction, and a lipid fraction;heating the mixture to a temperature in a range from about 50 degrees C. to about 100 degrees C. for a period of time sufficient to extract at least 80 percent of the lipids from the trap grease; andseparating a portion of the lipid fraction from the solid fraction.2. The method of claim 1 , wherein the vegetable oil is mixed with the trap grease at a ratio between about 1.5 ml:1 mg to about 4.5 ml:1 mg.3. The method of claim 1 , wherein the mixture of vegetable oil and trap grease is heated to a temperature in a range from about 55 degrees C. to about 85 degrees C.4. The method of claim 1 , wherein the mixture of vegetable oil and trap grease is heated to a temperature in a range from about 60 degrees C. to about 65 degrees C.5. The method of claim 1 , wherein the mixture of vegetable oil and trap grease is maintained at the desire temperature for a period of time from about 45 minutes to about 210 minutes.6. The method of claim 1 , wherein the separation step includes separating the lipid fraction from the solid fraction using a filtration process.7. The method of claim 1 , ...

WATER SOLUTION OF 20(R) - GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF

A preparation of a kind of 20(R)-ginsenoside Rg3 medicinal composition aqueous solution containing ginsenoside Rg3 0.5˜10 mg/ml: add 0.1-5% of ginsenoside solution to 0.1˜30% of adjuvant A, B{circle around (1)}{circle around (2)}{circle around (5)} at the temperature of 40˜100° C., the ratio of these two is 1:1˜300, add water after the solvent is recycled under reduced pressure; another kind of 20(R)-ginsenoside Rg3 medicinal composition aqueous solution contains 0.1˜2 mg/ml of 20 (R) of the ginsenoside Rg3, the preparation: add 0.1˜5% of ginsenoside solution to 20˜65% of adjuvant B{circle around (3)}{circle around (4)} at the temperature of 60˜100° C., main material to adjuvant B=1:100˜400, add water after the solvent is recycled under reduced pressure. The above 20 (R) ginsenoside Rg3 composition aqueous solution and the powder after lyophilizaton can be used to prepare injectable, oral administration and external use, and the bioactivity of these preparations is high, and with the actions of anti cancer, efficacy potentiation and toxicity attenuation effects of the combined chemical or radiation therapy of tumor, enhancement of human immune functions, improvement of human memory, anti fatigue, and detumescence, pain relieving. 1. An aqueous solution of a medicinal composition comprising a 20(R)-ginsenoside Rg3 , wherein the content of the ginsenoside Rg3 in the solution is 0.5˜10 mg/mL.2. A preparation process of an aqueous solution of a medicinal composition comprising a 20(R)-ginsenoside Rg3 , comprising step 1 , step 2 , step 3 and step 4 ,wherein step 1 comprises dissolving the 20(R)-ginsenoside Rg3 in a mixture of an organic solvent, and forming a solution comprising 0.1˜5% the ginsenoside;wherein step 2 comprises dissolving adjuvant A and adjuvant B {circle around (1)}{circle around (2)}{circle around (5)} in water, respectively, and forming an aqueous solution comprising 0.1˜30 wt % adjuvant A and adjuvant B;wherein step 3 comprises adding all the ...

Application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or/and treating viral diseases, and medicine or health care product for treating viral diseases

The present invention discloses a new application of a composition of phillyrin and phillygeninin in the preparation of drugs for alleviating or/and treating viral diseases. Experiments prove that the composition of phillyrin and phillygeninin has significant treatment effects on viral influenza and pneumonia, as well as on respiratory syncytial viruses, enteroviruses, herpes zoster simplex viruses, Coxsackie viruses, and the like. This composition is characterized by quick action and less toxic and side effects, and thus is an antiviral drug and health product with safety, high efficiency, stability and simple preparation process, and is suitable for industrial production and easy to promote. The present invention provides a new drug, health product and raw material for preventing and treating various viral diseases.

Process for making biofuel from spent coffee grounds

A system and process for producing biofuel from spent coffee grounds (SCGs) comprises the steps of performing a first operation comprising the steps of obtaining spent SCGs from a source, washing the SCGs, mixing the washed SCGs with an inorganic acid and heating and stirring the washed SCGs to form a SCG slurry without separating coffee oil, drying the SCG slurry, mixing the dried slurry with a solvent and heating the dried slurry and solvent mixture to create a reaction to produce biofuel and residual grounds, and separating the biofuel from the solvent and the residual grounds. The process further includes the step of using an activation agent and heating the residual grounds and the activation agent to create activated residual grounds. Biochar is also produced without activation and heating de-oiled SCGs at lower temperatures without oxygen.

APPLICATION OF A PHILLYRIN/PHILLYGENININ COMPOSITION IN PREPARING A MEDICINE OR HEALTH CARE PRODUCT FOR ALLEVIATING OR/AND TREATING VIRAL DISEASES, AND MEDICINE OR HEALTH CARE PRODUCT FOR TREATING VIRAL DISEASES

The present invention discloses a composition of phillyrin and phillygeninin in the preparation of drugs for alleviating or/and treating viral diseases. Experiments prove that the composition of phillyrin and phillygeninin has significant treatment effects on viral influenza and pneumonia, as well as on respiratory syncytial viruses, enteroviruses, herpes zoster simplex viruses, Coxsackie viruses, and the like. This composition is characterized by quick action and less toxic and side effects, and thus is an antiviral drug and health product with safety, high efficiency, stability and simple preparation process, and is suitable for industrial production and easy to promote. The present invention provides a drug, health product and raw material for preventing and treating various viral diseases. 1. A pharmaceutical composition for alleviating or/and treating a viral disease , wherein the pharmaceutical composition consists of phillyrin , phillygeninin and a pharmaceutically acceptable carrier , the ratio of phillyrin to phillygeninin in parts by weight is 80-98:2-20 , and the pharmaceutical composition contains no more antivirus components extracted from Forsythia suspense.2. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition is not the composition consisting of phillyrin claim 1 , phillygeninin and water.3. The pharmaceutical composition of claim 2 , wherein the pharmaceutical composition is not the composition consisting of phillyrin claim 2 , phillygeninin and sucrose.4. The pharmaceutical composition of claim 3 , wherein the viral disease is caused by a virus selected from the group consisting of influenza viruses claim 3 , parainfluenza viruses claim 3 , Coxsackie virus CoxA16 claim 3 , respiratory syncytial viruses claim 3 , herpes zoster simplex virus HSV-I claim 3 , herpes zoster simplex virus HSV-II claim 3 , herpes zoster simplex virus CVB3 claim 3 , adenovirus and enterovirus EV71.5. The pharmaceutical composition of claim 3 ...

Aqueous solution of 20(r)-ginsenoside rg3 pharmaceutical composition and process thereof

A 20(R)-ginsenoside Rg3 pharmaceutical composition water solution is prep ared by steps of adding ginsenoside solution into water solution of auxiliar y materials at the temperature of 400- 100 °C, recovering solvent and adding water.

WATER SOLUTION OF 20(R)-GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF

Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and process thereof

A 20(R)-ginsenoside Rg3 pharmaceutical composition water solution is prepared by steps of adding ginsenoside solution into water solution of auxiliary materials at the temperature of 400- 100 °C, recovering solvent and adding water.

Applications of phillyrin/phillygenin composition in preparing drugs or health care products for relieving and/or treating viral diseases

Applications of a phillyrin and phillygenin composition in preparing drugs or health care products for relieving and/or treating viral diseases.

20(R)-GINSENOSIDE Rg3 MEDICINAL SOLUBLE INTERMEDIATE AND PROCESS THEREOF

A medicinal water-soluble intermediate used for preparing injection is prepared through dissolving 20(R)-ginsenoside Rg3 in an organic solvent, dissolving 2-hydroxypropyl -β-cyclodextrin in water to obtain aqueous solution, heating it to 40-100°C, stirring while dripping ginsenoside solution, recovering of solvent, and dissolving in the water for injection.

Rotary press-in mechanism of blind rod machine

盲杆机旋转压入机构，包括：伺服电机、旋转搬料机构、盲棍压入机构、真空吸机构、喷管，所述旋转搬料机构包括：转子、两个轴承、转轴，两个轴承嵌套在转轴上，转子与转轴联动，转轴与伺服电机联动,转子的外壁设置有至少两个竖直的槽；所述盲棍压入机构设置有两组，位于旋转搬料机构的槽的上方；所述喷管安装在旋转搬料机构的槽的下方，所述喷管设置有两组，分别与两组盲棍压入机构上下对应，机构紧凑、双向搬料、定位精准、高效搬料。

Composições com extrato de forsythia suspensa, forsitina e derivados de forsitina, filigenina e componente opcional panax ginseng e aplicações

COMPOSIÇÕES COM EXTRATO DE FORSYTHIA SUSPENSA, FORSITINA E DERIVADOS DE FORSITINA, FILIGENINA E COMPONENTE OPCIONAL PANAX GINSENG E APLICAÇÕES. A presente invenção revela uma composição do componente Forsythia suspensa e um componente opcional Panax ginseng que pode ser usado com segurança, eficiência e estabilidade para obter efeitos antivirais, antipiréticos, anti-inflamatórios e/ou de aumento da imunidade, incluindo forsitina, derivados de forsitina e a composição de forsitina e filigenina para a prevenção e tratamento de doenças associadas à infecção por citomegalovírus humano, como infecção simples por citomegalovírus humano ou pacientes infectados por citomegalovírus humano durante a prevenção e tratamento de doenças cardiovasculares e cerebrovasculares, tumores, queimaduras ou AIDS ou durante o processo de transplante de órgãos ou durante o período perinatal, onde o processo de preparação da composição dos componentes Forsythia suspensa e Panax ginseng é simples, adequado para produção industrial e fácil de popularizar.

Functionalized carbon nanocone tip and preparation method therefor

Soft threshold defense method for adversarial examples of remote sensing images

A soft threshold defense method for adversarial examples of remote sensing images includes: saving correctly classified remote sensing images and adversarial examples in a validation set under a same class, and removing remote sensing images that cannot be correctly classified in the validation set; re-classifying the images saved in the validation set by treating original images as positive samples and the adversarial examples as negative samples; obtaining a new dataset by combining the output confidences of classes; training a logistic regression model on the dataset; obtaining thresholds of the output confidences through decision boundaries of original images and adversarial examples; and determining whether a current input image is an adversarial example by comparing an output confidence of the current input image with the soft threshold used for defense. Attack of adversarial examples in the scene classification problem of remote sensing images can be effectively defended. 21006ZCM-AUP2 Positive: correctly classified RSIS soft threshold Negative: adversarial examples U pooling layer classifiers RSI convolutional fully connected softthreshold layer layer confidence > soft threshold? predictconfidence If Ture, Safe per class soft threshold If False, Unsafe FIG. 1 1 21006ZCM-AUP2

Compositions of ginsenoside rg3 and ginsenoside rg5 and their pharmaceutical uses including anti-tumor effects

The present invention discloses a composition of ginsenoside Rg3 and ginsenoside Rg5 and a preparation method thereof, as well as its application in manufacturing drugs, foods and health products for boosting immunity, enhancing anti-tumor effects, improving resistance to anti-tumor targeted drugs, mitigating toxic and side effects of radiotherapy and chemotherapy or improving anti-fatigue effects. The composition has advantages in rapid action, less toxicity and side effects and is suitable for long-term use. It is a kind of safe, highly efficient and stable drug, food and health products that requires simple preparation process, is suitable for industrial production and can be easily popularized. The present invention provides a new type of raw material and production process for manufacturing drugs, foods and health products for boosting immunity, enhancing anti-tumor effect, improving resistance to anti-tumor targeted drugs, mitigating toxic and side effects of radiotherapy and chemotherapy or improving anti-fatigue effect.

Composições de ginsenosídeo rg3 e ginsenosídeo rg5 e seus usos farmacêuticos, incluindo efeitos antitumorais

COMPOSIÇÕES DE GINSENOSÍDEO RG3 E GINSENOSÍDEO RG5 E SEUS USOS FARMACÊUTICOS, INCLUINDO EFEITOS ANTITUMORAIS. A presente invenção divulga uma composição de ginsenosídeo Rg3 e ginsenosídeo Rg5 e um método de preparação dos mesmos, bem como sua aplicação na fabricação de medicamentos, alimentos e produtos de saúde para aumentar a imunidade, aprimorar os efeitos antitumorais, melhorar a resistência do direcionamento do efeito antitumoral dos medicamentos, atenuar efeitos tóxicos e colaterais da radioterapia e quimioterapia ou melhorando os efeitos anti-fadiga. A composição apresenta vantagens de ação rápida, menor toxicidade e efeitos colaterais e é adequada para uso prolongado. É um tipo de medicamento, alimento e produto de saúde seguro, altamente eficiente e estável que requer processo de preparação simples, é adequado para produção industrial e pode ser facilmente popularizado. A presente invenção fornece um novo tipo de matéria-prima e processo de produção para a fabricação de medicamentos, alimentos e produtos de saúde para aumentar a imunidade, aprimorar o efeito antitumoral, melhorar a resistência do direcionamento do efeito antitumoral dos medicamentos, atenuar os efeitos tóxicos e colaterais da radioterapia e quimioterapia ou melhorar o efeito anti-fadiga.

Compositions of ginsenoside rg3 and ginsenoside rg5 and their pharmaceutical uses including anti-tumor effects

In one aspect, a composition of ginsenoside Rg3 and ginsenoside Rg5 and a preparation method thereof, as well as its application in manufacturing drugs, foods and health products for boosting immunity, enhancing anti-tumor effects, improving resistance to anti-tumor targeted drugs, mitigating toxic and side effects of radiotherapy and chemotherapy or improving anti-fatigue effects. The composition has advantages in rapid action, less toxicity and side effects and is suitable for long-term use. In another aspect, a safe, highly efficient and stable drug, food or health product which can be obtained by a simple preparation process suitable for industrial production and which can be easily scaled up. In yet another aspect, a new type of components and production process for manufacturing drugs, foods and health products for boosting immunity, enhancing anti-tumor effect, improving resistance to anti-tumor targeted drugs, mitigating toxic and side effects of radiotherapy and chemotherapy or improving anti-fatigue effect.

Forsythiae fructus component and optional ginseng component, and use thereof

The present invention discloses a composition of forsythia suspensa component and an optional panax ginseng component that can be used safely, efficiently and stably to achieve the antiviral, antipyretic, anti-inflammatory and/or immunity boosting effects, including forsythin, forsythin derivatives, and the composition of forsythin and phillygenin for the prevention and treatment of diseases associated with human cytomegalovirus infection, such as simple human cytomegalovirus infection or patients infected by human cytomegalovirus during the prevention and treatment of cardiovascular and cerebrovascular diseases, tumors, burns or AIDS or during the process of organ transplantation or during the perinatal period. Wherein, the process for preparing the composition of forsythia suspensa and panax ginseng components is simple, suitable for industrial production and easy to popularize.

3clpro-targeting phillyrin, derivative thereof, and use thereof against novel coronavirus

Disclosed are phillyrin that targets the 3CLpro protein, which inhibits the COVID-19 virus, a derivative thereof, and the use of a composition of phillyrin and phylligenin in the preparation of a drug for resisting a coronavirus or treating a disease caused by a coronavirus, wherein the coronavirus is the COVID-19 virus and the disease caused by a coronavirus is COVID-19.

Uso de forsitina e/ou seus derivados, método para a inibição da proteína 3clpro do vírus covid-19, uso de composição de forsitina/forsitosídeo, métodos para uso contra o vírus covid-19 ou para o tratamento de doenças causadas pelo vírus covid-19, composição de forsitina/forsitosídeo e medicamento compreendendo uma composição de forsitina/forsitosídeo

USO DE FORSITINA E/OU SEUS DERIVADOS, MÉTODO PARA A INIBIÇÃO DA PROTEÍNA 3CLpro DO VÍRUS COVID-19, USO DE COMPOSIÇÃO DE FORSITINA/FORSITOSÍDEO, MÉTODOS PARA USO CONTRA O VÍRUS COVID-19 OU PARA O TRATAMENTO DE DOENÇAS CAUSADAS PELO VÍRUS COVID-19, COMPOSIÇÃO DE FORSITINA/ FORSITOSÍDEO E MEDICAMENTO COMPREENDENDO UMA COMPOSIÇÃO DE FORSITINA/FORSITOSÍDEO. A presente invenção prevê o uso de uma composição de forsitina/forsitosídeo, que tem como alvo e inibe a proteína 3CLpro do vírus COVID-19, na fabricação de um medicamento anticoronavírus ou para o tratamento de doenças causadas por coronavírus. Em que o coronavírus é o vírus COVID-19 e a doença causada pelo coronavírus é a COVID-19.

3clpro-targeting phillyrin, derivative thereof, and use thereof against novel coronavirus

The present invention provides a use of a phillyrin/phillygenin composition which targets and inhibits 3CLpro protein of COVID-19 virus, in preparation of an anti-coronavirus drug or a drug for treating a disease caused by the coronavirus, wherein the coronavirus is COVID-19 virus, and the disease caused by the coronavirus is COVID-19.

有方向盲棍供料机构

有方向盲棍供料机构，包括：圆震机构、直震机构、圆震缺料感应器、直震满料感应器，所述圆震缺料感应器设置于圆震机构后方，所述直震机构在圆震机构的侧前方，所述直震满料感应器置于直震机构上，本实用新型提供的有方向盲棍供料机构结构简单、使用方便、高效输送。

盲栓机ng产品收集机构

盲栓机NG产品收集机构，NG滑道、挡片、NG对射感应器、取料门、取料门锁，所述挡片安装于NG滑道上部入口处，所述NG对射感应器由前后两组对射感应器组成，分别安装于NG滑道PC板的两侧；所述取料门安装于NG滑道的底部出口处，当NG滑道满料或需要取料时，打开此门即可取料，不合格产品由NG滑道入口处放入，经过两组对射感应器，两组对射感应器会分别感应到产品经过信号，从而确认被视觉检测出不合格产品已被放入NG收集机构内。当NG收集机构内物料堆满到第二道对射感应器处时，第二道对射感应器会长时间不间断的接受信号，这时设备会提醒操作员NG收集机构已满料，需要打开取料门，把不合格产品统一收集到其他处或返工。

3clpro-targeting phillyrin, derivative thereof, and use thereof against novel coronavirus

Forsythia suspensa component and optional panax ginseng component and the application

In one aspect, the present invention discloses a composition of forsythia suspensa component and an optional panax ginseng component that can be used safely, efficiently and consistently to achieve antiviral, antipyretic, anti-inflammatory and/or immunity boosting effects, including forsythin, forsythin derivatives, and the composition of forsythin and phillygenin for the prevention and treatment of diseases associated with human cytomegalovirus infection, such as simple human cytomegalovirus infection or for patients infected by human cytomegalovirus during prevention and treatment of cardiovascular and cerebrovascular diseases, tumors, bums or AIDS or during a process of organ transplantation or during the perinatal period. In another aspect, this application provides a process for preparing the composition of forsythia suspensa and panax ginseng components is simple, suitable for industrial production and easy to popularize.

3clpro-targeting phillyrin, derivative thereof, and use thereof against novel coronavirus

The present invention provides a use of a phillyrin/phillygenin composition which targets and inhibits 3CLpro protein of COVID-19 virus, in preparation of an anti-coronavirus drug or a drug for treating a disease caused by the coronavirus, wherein the coronavirus is COVID-19 virus, and the disease caused by the coronavirus is COVID-19.

Forsythiae fructus component and optional ginseng component, and use thereof

Forsythiae fructus component and optional ginseng component, and use thereof

Provided is a composition with antiviral, antipyretic, anti-inflammatory and/or immunity-improving effects, which composition comprises a Forsythiae fructus component and can also comprise a Ginseng component, wherein the Forsythiae fructus component is phillyrin, a phillyrin derivative or a composition of phillyrin and phillygenin. The composition can be used for preparing drugs or food products or health-care products having corresponding functions, and can also be used for preparing anti-cytomegalovirus preparations.

3clpro-targeting phillyrin, derivative thereof, and use thereof against novel coronavirus

Disclosed are phillyrin that targets the 3CLpro protein, which inhibits the COVID-19 virus, a derivative thereof, and the use of a composition of phillyrin and phylligenin in the preparation of a drug for resisting a coronavirus or treating a disease caused by a coronavirus, wherein the coronavirus is the COVID-19 virus and the disease caused by a coronavirus is COVID-19.

System to reuse fats, oils, and grease

A method of forming a yellow grease is provided. The method includes delivering a FOG lipid extraction agent into a processing tank. The method further includes preheating an FOG to a temperature of between 35° C. and 95° C. The method further includes mixing the preheated waste grease with the FOG lipid extraction agent in the processing tank to form the yellow grease.

Antiviral use of bisepoxylignan compound, and bisepoxylignan composition and preparation of bisepoxylignan compound

The present invention provides an application of a bisepoxylignan compound or a bisepoxylignan composition in prevention and treatment of infections with influenza viruses, parainfluenza viruses, COVID-19 viruses and COVID-19 virus variants, an application thereof in prevention and treatment of pulmonary hemorrhage caused by the COVID-19 viruses and the COVID-19 virus variants (e.g., Delta), an application thereof in anti-inflammatory effects on pneumonia caused by influenza viruses, parainfluenza viruses, COVID-19 viruses and COVID-19 virus variants. In addition, the present invention further provides a chemical synthesis method of a bisepoxylignan compound lianqiaoxinside.

Composition of ginsenosides rg3 and rg5 and anti-tumor pharmaceutical use thereof

A composition of ginsenoside Rg3 and ginsenoside Rg5, a preparation method therefor, and applications thereof in preparation of medications capable of improving drug resistance of immune, anti-tumor, and anti-tumor targeted medications, and reducing toxic and side reactions in radiotherapy and chemotherapy or resisting fatigue, and in preparation of food and health care products.

覆膜机导辊检查灯具

本实用新型涉及覆膜机导辊检测安装设备技术领域，尤其是一种覆膜机导辊检查灯具，包括安装在导轨外侧的固定支架和安装在固定支架上的LED检测灯体。本实用新型的覆膜机导辊检查灯具通过固定安装在导轨外侧的固定支架来固定安装LED检测灯体，扫描杜绝人员靠近正在运行中的导辊，避免出现安全事故，同时减少外界带入的灰尘杂质，保证产品质量，在固定架外侧面上通过螺栓固定安装顶部插接有伸缩翻转装配杆的侧向翻转架，利用固定螺栓分别插入弧形调节口和侧向装配通孔内部来同时固定侧向翻转架和伸缩翻转装配杆的角度和位置，使得检查灯具的安装调节更加方便，安装位置更加多样化，适用范围更加广泛。

Anti-inflammatory application of ginsenoside rd

The present invention discloses a novel application of ginsenoside Rd in preparation of a drug for relieving or/and treating inflammations and health food/medicinal and edible food/functional food/dietary supplement. Tests prove that ginsenoside Rd has a remarkable curative effect on inflammations, takes effect quickly, has a better effect than Dexamethasone, is suitable for both acute inflammations such as influenza virus pneumonia, novel coronavirus pneumonia and acute lung injury inflammations, and chronic inflammations such as chronic obstructive pneumonia and chronic asthmatic airway inflammations, and is regarded as a new drug source for treating acute and chronic inflammations and complications thereof.

Composition of ginsenosides rg3 and rg5 and anti-tumor pharmaceutical use thereof